Canonical and emerging regulatory mechanisms of tissue remodeling: shared principles across organs and therapeutic opportunities
-
By
-
Meiyu Wu
-
Zichao Han
-
Wenhao Wei
-
Yewen Niu
-
Hao Wang
-
Fanchao Meng
-
Qingmei Wu
-
June 5, 2026
-
Clinical Scorecard: Regulatory Pathways in Tissue Remodeling: Common Mechanisms Across Organs and Potential Therapeutic Insights
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | TGF-β superfamily, MMPs/TIMPs system, mechanotransduction, metabolic reprogramming, ncRNA regulation, glycolysis-HIF-mTOR |
| Target Population | |
| Care Setting | |
Key Highlights
- Tissue remodeling is regulated by complex signaling networks.
- Dysregulation can lead to chronic diseases and organ dysfunction.
- Core pathways include TGF-β signaling and MMPs/TIMPs imbalance.
- Emerging mechanisms involve mechanotransduction, metabolic reprogramming, and immune cell interactions.
- ncRNAs play a role in epigenetic regulation of remodeling processes.
Guideline-Based Recommendations
Diagnosis
- Identify persistent inflammation and ECM imbalance as key indicators of pathological remodeling.
Management
- Target TGF-β signaling and MMPs/TIMPs balance in therapeutic strategies.
Monitoring & Follow-up
- Assess changes in tissue stiffness, fibroblast activity, and metabolic changes as part of disease progression.
Risks
- Increased tissue stiffness and ECM accumulation can lead to organ dysfunction.
Patient & Prescribing Data
Patients with chronic inflammatory diseases
Focus on interventions that modulate inflammatory responses and ECM dynamics.
Clinical Best Practices
- Utilize a multidisciplinary approach to understand tissue remodeling mechanisms.
- Incorporate emerging research on metabolic reprogramming in treatment plans.
- Monitor inflammatory markers, ECM components, and immune cell activity in patient assessments.
Related Resources & Content
